Effectiveness Analysis of Natalizumab versus Fingolimod using Patient-Reported Outcomes in Patients with Multiple Sclerosis

Primary Objective

The purpose of this study is to compare two medications, natalizumab and fingolimod, used in the treatment of multiple sclerosis (MS) through a variety of previously validated patient reported outcomes (PROs).

This Study is
No Longer Enrolling

Details
Age

Child to Adult

Phase

Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.

Type of Study

Observational

Locations

University of Colorado Hospital

Study ID

Protocol Number: 13-2767

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers